viewValiRx PLC

ValiRx working on options to hold a meeting to vote on vital cash lifeline

The company adjourned the general meeting that was to be held on 25 March 2020 as a result of the COVID-19 situation

ValiRx PLC -

ValiRx PLC (LON:VAL) has said it is reviewing its options to reconvene a meeting to vote on resolutions that could lead to a cash lifeline for the company.

The cash-strapped firm is in discussions with a number of potential funders who have indicated conditional willingness to invest in the company in the event that certain resolutions are passed but the meeting that was called for March 25 to vote on these resolutions was adjourned as a result of the coronavirus (COVD-19) situation.

The company remains dependent on the support of its creditors in order to continue trading.

Quick facts: ValiRx PLC

Price: 7.25 GBX

Market: AIM
Market Cap: £2.61 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of ValiRx PLC named herein, including the promotion by the Company of ValiRx PLC in any Content on the Site, the Company receives from said issuer...



ValiRx Plc enjoying strong industry interest in its cancer treatments

George Morris, chief operations officer at ValiRx Plc (LON:VAL), updates Proactive's Andrew Scott on developments across the company's portfolio. Morris says advanced conversations are continuing with possible partners as they look to press ahead with the development of their flagship...

on 19/7/18

2 min read